Nevertheless, programming neutrophils to the anti-inflammatory N2 subtype by a Peroxisome proliferator-activated receptor gamma PPARγ agonist has been used to obtain a beneficial outcome in stroke (Cuartero et al. 2013). This evidence concerns the gene PPARG and Stroke.